Chemotherapy News and Research

Latest Chemotherapy News and Research

Breast cancer patients treated with chemotherapy show improved executive function after cognitive training

Women whose breast cancer had been treated with chemotherapy demonstrated improved executive function, such as cognitive flexibility, verbal fluency and processing speed after using exercises developed by Lumosity, the leading online cognitive training program.

15 May 2013

Novel drug may increase the effectiveness of radiation therapy for brain cancer

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.

15 May 2013

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.

15 May 2013

ALKBH7 protein plays key role in controlling programmed necrosis pathway

When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their DNA.

15 May 2013

Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Colorectal cancer is the third most common cancer in men and second in women, with over 1.2 million cases diagnosed worldwide in 2008.

14 May 2013

Inhibiting powerful protein with new agents may supply broad benefit for lymphoma patients

A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein.

14 May 2013

Annual Century for the Cure bike ride supports research on hematologic malignancies

The annual Century for the Cure bike ride that has raised more than $1 million since 2005 for research at The Cancer Institute of New Jersey is now making it possible for new scientific exploration in the area of hematologic malignancies.

14 May 2013

Roundup: NYC examines solitary confinement alternatives for mentally ill inmates; Texas lawmakers push to modernize medical practices; N.C. cancer parity bill passes House

New York City will soon change the way mentally ill inmates are disciplined after breaking rules while in jail, creating alternatives to the more traditional approach of solitary confinement used for most inmates (Yee, 5/12).

14 May 2013

Medicare reveals what hospitals charge for many procedures

News outlets continue plumbing newly released federal data that details for the first time what hospitals charge for some of the most common in-patient procedures.

14 May 2013

First Edition: May 13, 2013

Today's headlines include reports that Health and Human Services Secretary Kathleen Sebelius has been seeking out funds from private sources to support efforts to publicize the health law.

13 May 2013

Research reports adolescents, young adults with cancer may be at higher risk for social isolation

Research conducted by Xiao-Cheng Wu, MD, PhD, Associate Professor and Director of the Louisiana Tumor Registry at the LSU Health Sciences Center New Orleans School of Public Health, and colleagues, reports adolescents and young adults with cancer may be at higher risk for social isolation and that a substantial proportion of them have unmet social needs that could adversely affect their health.

10 May 2013

AWHR participates in the Relay For Life of Palm Bay event to support cancer research

AWHR was proud to participate in the Relay For Life of Palm Bay event on April 6, 2013. Eight AWHR employees participated in the event along with 44 other teams and more than 600 participants!

10 May 2013

Researchers find a way the body can remove injured axons

Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other parts of the body, allowing movement, sight and sense of touch, among other vital functions.

10 May 2013

Researchers discover novel mechanism of tumor hypoxia

An article published recently in Tumor Microenvironment and Therapy - an open access journal by Versita, defines a novel mechanism of tumor hypoxia induced by the longitudinal gradient of residual oxygen along tumor vessels as they transverse the tumor.

10 May 2013

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.

9 May 2013

First Edition: May 9, 2013

Today's headlines include reports about the politics surrounding the health law, both in terms of the latest GOP push for repeal and the Obama administration's implementation efforts.

9 May 2013

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Precision Therapeutics, Inc., a life science company that develops personalized medicine products for individualizing cancer care, today announced that a clinical study which demonstrates the feasibility of the ChemoFx chemoresponse assay to identify patients unlikely to respond to first-line therapy has been accepted for presentation at the 2013 Annual Meeting of the Western Association of Gynecologic Oncologists.

9 May 2013

Chemotherapy News and Research

Latest Chemotherapy News and Research

Breast cancer patients treated with chemotherapy show improved executive function after cognitive training

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

ALKBH7 protein plays key role in controlling programmed necrosis pathway

Bowel cancer survival in the UK: an interview with Camille Maringe, London School of Hygiene and Tropical Medicine

Inhibiting powerful protein with new agents may supply broad benefit for lymphoma patients

Annual Century for the Cure bike ride supports research on hematologic malignancies

Roundup: NYC examines solitary confinement alternatives for mentally ill inmates; Texas lawmakers push to modernize medical practices; N.C. cancer parity bill passes House

Medicare reveals what hospitals charge for many procedures

First Edition: May 13, 2013

Research reports adolescents, young adults with cancer may be at higher risk for social isolation

AWHR participates in the Relay For Life of Palm Bay event to support cancer research

Researchers find a way the body can remove injured axons

Researchers discover novel mechanism of tumor hypoxia

Mathematical model with prognostic factors predicts treatment effect with bevacizumab in colorectal cancer patients

First Edition: May 9, 2013

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Study: Patients are more likely to have recurrence of cancer after bladder removal

Patients with ASPS appear to benefit from anti-cancer drug, cediranib

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in